Two weeks after the second immunization with MMC-treated MC38 CRC cells plus 40 μg of rGRA6Nt adjuvant, CD4+ and CD8+ T cells were purified from their spleens and cultured with and without MMC-treated MC38 CRC cells for 72 h. The gene discussed is CD8A; the disease is colorectal carcinoma.